Section Arrow
CBUS.NASDAQ
- Cibus
Quotes are at least 15-min delayed:2024/05/16 02:01 EDT
Last
 18.7
-0.29 (-1.53%)
Day High 
19 
Prev. Close
18.99 
1-M High
19.5624 
Volume 
39.48K 
Bid
17.67
Ask
19.63
Day Low
18.4001 
Open
18.99 
1-M Low
14.36 
Market Cap 
468.82M 
Currency USD 
P/E -- 
%Yield
10-SMA 17.63 
20-SMA 16.76 
50-SMA 18.45 
52-W High 38.85 
52-W Low 8.9 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-21.61/-3.15
Enterprise Value
486.49M
Balance Sheet
Book Value Per Share
11.27
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
1.82M
Operating Revenue Per Share
0.01
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
DNAGinkgo Bioworks Holdings0.8391-0.0237-2.75%-- 
NVAXNovavax12.9-0.58-4.30%-- 
JAGXJaguar Health0.2551-0.0198-7.20%-- 
OCGNOcugen1.96+0.26+15.29%-- 
ARQTArcutis Biotherapeutics9.24+1.11+13.65%-- 
Quotes are at least 15-min delayed:2024/05/16 02:01 EDT
Industry overview quotes are at least 15 minutes delayed
Business Description
Cibus Inc is a biotechnology company. The company develops and commercializes a proprietary gene-editing technology, Rapid Trait Development System that integrates crop specific cell biology platforms with a series of gene editing technologies. The company's primary business is the development of plant traits that help address specific productivity or yield challenges in farming such as traits addressing plant agronomy, disease, insects, weeds, nutrient-use, or the climate.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.